ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990

Texts Of Workshop Report Summarized

November 8, 1996

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

Florida Creates State Cancer Control Program

August 10, 1979

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

Congress Approves $4.19 Billion For NCI, $23.5 Billion For NIH, In FY2002 Appropriation.

January 4, 2002